ORCID as entered in ROS
![orcid_icon](/themes/resgate8/images/icons/ORCIDiD_icon24x24.png)
Select Publications
2020, '17891 Quality of life score in Indian patients with epidermolysis bullosa and its correlation with clinical severity assessment scores', Journal of the American Academy of Dermatology, 83, pp. AB202 - AB202, http://dx.doi.org/10.1016/j.jaad.2020.06.896
,2020, '282 Larger wounds in recessive dystrophic epidermolysis bullosa patients associated with worse quality of life: Results of a global cross-sectional survey', Journal of Investigative Dermatology, 140, pp. S34 - S34, http://dx.doi.org/10.1016/j.jid.2020.03.288
,2019, 'Inter-rater reliability of the BIOCHIP indirect immunofluorescence dermatology mosaic in bullous pemphigoid and pemphigus patients', Journal of the European Academy of Dermatology and Venereology, 33, pp. 2327 - 2333, http://dx.doi.org/10.1111/jdv.15817
,2019, 'Monitoring trough levels in cyclosporine for atopic dermatitis: A systematic review', Pediatric Dermatology, 36, pp. 843 - 853, http://dx.doi.org/10.1111/pde.13999
,2019, 'Mycobacterium chelonae infection mimicking demodex folliculitis.', Clin Exp Dermatol, http://dx.doi.org/10.1111/ced.14132
,2019, 'What is novel in the clinical management of pemphigus', Expert Review of Clinical Pharmacology, 12, pp. 973 - 980, http://dx.doi.org/10.1080/17512433.2019.1670059
,2019, 'Patients left behind: Rare dermatologic conditions miss the orphan drug development boom', Journal of the American Academy of Dermatology, 81, pp. 1025 - 1026, http://dx.doi.org/10.1016/j.jaad.2019.03.013
,2019, 'Prevalence and pathogenesis of osteopenia and osteoporosis in epidermolysis bullosa: An evidence-based review', Experimental Dermatology, 28, pp. 1122 - 1130, http://dx.doi.org/10.1111/exd.13771
,2019, 'Epidermolizis bülloza yaşam kalitesi puanlarının klinik uygulamalarının geliştirilmesi: QOLEB anketinde klinik olarak anlamlı sonuçların tanımlanması', Mucosa, 2, pp. 68 - 75, http://dx.doi.org/10.33204/mucosa.598339
,2019, 'Toxicity of glucocorticosteroids in autoimmune blistering diseases', Mucosa, 2, pp. 59 - 67, http://dx.doi.org/10.33204/mucosa.607952
,2019, 'A chlorhexidine conundrum after an epidural delivery: The difficulty of differentiating between chlorhexidine burns and hypersensitivity reactions', International Journal of Women's Dermatology, 5, pp. 269 - 270, http://dx.doi.org/10.1016/j.ijwd.2019.04.023
,2019, 'Introduction to the clinical images section', International Journal of Women's Dermatology, 5, pp. 213, http://dx.doi.org/10.1016/j.ijwd.2019.06.001
,2019, 'Review of autoimmune blistering diseases: the Pemphigoid diseases', Journal of the European Academy of Dermatology and Venereology, 33, pp. 1685 - 1694, http://dx.doi.org/10.1111/jdv.15679
,2019, 'Alopecia in Autoimmune Blistering Diseases: A Systematic Review of Pathogenesis and Clinical Features of Disease', Skin Appendage Disorders, 5, pp. 263 - 275, http://dx.doi.org/10.1159/000496836
,2019, 'Assessment of the quality of life of egyptian and tunisian autoimmune bullous diseases' patients using an arabic version of the autoimmune bullous disease quality of life and the treatment of autoimmune bullous disease quality of life questionnaires', Anais Brasileiros de Dermatologia, 94, pp. 399 - 404, http://dx.doi.org/10.1590/abd1806-4841.20197198
,2019, 'Autoimmune bullous diseases during pregnancy: Solving common and uncommon issues', International Journal of Women's Dermatology, 5, pp. 166 - 170, http://dx.doi.org/10.1016/j.ijwd.2019.01.003
,2019, 'Cutaneous leishmaniasis: A neglected disfiguring disease for women', International Journal of Women's Dermatology, 5, pp. 158 - 165, http://dx.doi.org/10.1016/j.ijwd.2019.01.002
,2019, 'Introduction to The Art of Prevention series', International Journal of Women's Dermatology, 5, pp. 151, http://dx.doi.org/10.1016/j.ijwd.2019.05.004
,2019, 'Pathogenesis and clinical features of alopecia in epidermolysis bullosa: A systematic review', Pediatric Dermatology, 36, pp. 430 - 436, http://dx.doi.org/10.1111/pde.13866
,2019, 'Pemphigus vulgaris accompanied with amyotrophic lateral sclerosis: a rare coincidence or pathogenic relationship?', European Journal of Dermatology, 29, pp. 435 - 436, http://dx.doi.org/10.1684/ejd.2019.3577
,2019, 'Successful management of bullous pemphigoid with dimethyl fumarate therapy: A case report', International Journal of Women's Dermatology, 5, pp. 179 - 180, http://dx.doi.org/10.1016/j.ijwd.2019.02.001
,2019, 'Is it psoriasis, a virus, or fungal infection?', Australian Doctor
,2019, 'Pharmacological advances in pemphigus', Current Opinion in Pharmacology, 46, pp. 44 - 49, http://dx.doi.org/10.1016/j.coph.2019.01.001
,2019, 'Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: Final update of the pivotal ERIVANCE BCC study (BMC Cancer. (2017) 17 (332) DOI: 10.1186/s12885-017-3286-5)', BMC Cancer, 19, http://dx.doi.org/10.1186/s12885-019-5568-6
,2019, 'Quality of life in turkish patients with autoimmune blistering diseases: Reliability and validity of the autoimmune bullous disease quality of life and the treatment of autoimmune bullous disease quality of life questionnaires', Turkish Journal of Dermatology, 13, pp. 83 - 90, http://dx.doi.org/10.4103/tjd.tjd_16_19
,2019, 'Association between bullous pemphigoid and psoriasis: Systematic review and meta-analysis of case-control studies', Australasian Journal of Dermatology, 60, pp. 23 - 28, http://dx.doi.org/10.1111/ajd.12899
,2019, 'Diagnostic Criteria and Phenotypes of Pemphigoid and the Association with Gliptins', JAMA Dermatology, 155, pp. 147 - 148, http://dx.doi.org/10.1001/jamadermatol.2018.4847
,2019, 'Epidermolysis Bullosa Patients' Perception of Surgical Wound and Scar Healing', Dermatologic Surgery, 45, pp. 280 - 289, http://dx.doi.org/10.1097/DSS.0000000000001673
,2019, 'A new indirect immunofluorescence BIOCHIP method for the serological diagnosis of bullous pemphigoid: A review of literature', Australasian Journal of Dermatology, 60, pp. e173 - e177, http://dx.doi.org/10.1111/ajd.13034
,2019, 'Editorial: Skin blistering diseases', Frontiers in Medicine, 6, http://dx.doi.org/10.3389/fmed.2019.00060
,2019, 'Large International Validation of ABSIS and PDAI Pemphigus Severity Scores', Journal of Investigative Dermatology, 139, pp. 31 - 37, http://dx.doi.org/10.1016/j.jid.2018.04.042
,2019, 'Pemphigus vulgaris disease activity: The role of antibodies to desmogleins and their isotype', Journal of Oral Pathology and Medicine, 48, pp. 619 - 625, http://dx.doi.org/10.1111/jop.12913
,2019, 'Assessment of the quality of life of Egyptian and Tunisian autoimmune bullous diseases' patients using an Arabic version of the autoimmune bullous disease quality of life and the treatment of autoimmune bullous disease quality of life questionnaires.', An Bras Dermatol, 94, pp. 399 - 404, http://dx.doi.org/10.1590/abd1806-4841.20197198
,2019, 'Comment les experts internationaux traitent-ils les patients atteints de pemphigoïde bulleuse à travers le monde ?', Annales de Dermatologie et de Vénéréologie, 146, pp. A62 - A62, http://dx.doi.org/10.1016/j.annder.2019.09.039
,2019, 'Corrélations entre les questionnaires de qualité de vie spécifiques aux maladies bulleuses auto-immunes ABQOL et TABQOL, et les scores de sévérité objectifs', Annales de Dermatologie et de Vénéréologie, 146, pp. A97 - A98, http://dx.doi.org/10.1016/j.annder.2019.09.100
,2019, 'Multiple milia formation in blistering diseases', International Journal of Women's Dermatology, 5, pp. 275 - 275, http://dx.doi.org/10.1016/j.ijwd.2019.06.004
,2018, 'Probiotics for treating eczema', Cochrane Database of Systematic Reviews, 2018, http://dx.doi.org/10.1002/14651858.CD006135.pub3
,2018, 'The effect of autoimmune blistering diseases on work productivity', Journal of the European Academy of Dermatology and Venereology, 32, pp. 1959 - 1966, http://dx.doi.org/10.1111/jdv.15062
,2018, 'Is the Oral Disease Severity Score going to be useful for dermatologists when assessing pemphigus?', British Journal of Dermatology, 179, pp. 816 - 817, http://dx.doi.org/10.1111/bjd.16911
,2018, 'Normocomplementaemic urticarial vasculitis: Effective treatment with omalizumab', Clinical and Translational Allergy, 8, http://dx.doi.org/10.1186/s13601-018-0222-y
,2018, 'Pemphigoid gestationis and intravenous immunoglobulin therapy', International Journal of Women's Dermatology, 4, pp. 166 - 169, http://dx.doi.org/10.1016/j.ijwd.2018.03.007
,2018, 'The effects of autoimmune blistering diseases on work productivity: A review', International Journal of Women's Dermatology, 4, pp. 131 - 138, http://dx.doi.org/10.1016/j.ijwd.2017.11.001
,2018, 'APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa', Science Translational Medicine, 10, http://dx.doi.org/10.1126/scitranslmed.aas9668
,2018, 'Chinese version of the treatment of autoimmune bullous disease quality of life questionnaire: Reliability and validity', Indian Journal of Dermatology, Venereology and Leprology, 84, pp. 431 - 436, http://dx.doi.org/10.4103/ijdvl.ijdvl_538_16
,2018, 'International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisita', British Journal of Dermatology, 179, pp. 30 - 41, http://dx.doi.org/10.1111/bjd.16138
,2018, 'New biochip immunofluorescence test for the serological diagnosis of pemphigus vulgaris and foliaceus: A review of the literature', International Journal of Women's Dermatology, 4, pp. 102 - 108, http://dx.doi.org/10.1016/j.ijwd.2017.10.001
,2018, 'A review of scoring systems for ocular involvement in chronic cutaneous bullous diseases', Orphanet Journal of Rare Diseases, 13, pp. 83, http://dx.doi.org/10.1186/s13023-018-0823-5
,2018, 'Osteopenia is common in mild forms of epidermolysis bullosa', JOURNAL OF INVESTIGATIVE DERMATOLOGY, 138, pp. S45 - S45, http://dx.doi.org/10.1016/j.jid.2018.03.271
,2018, 'Reliability of the BIOCHIP in pemphigus and pemphigoid patients the evaluations of blistering disease experts', JOURNAL OF INVESTIGATIVE DERMATOLOGY, 138, pp. S10 - S10, http://dx.doi.org/10.1016/j.jid.2018.03.063
,2018, 'Mucous membrane pemphigoid affecting the epiglottis and response to intravenous immunoglobulin therapy', Otolaryngology Case Reports, 6, pp. 1 - 3, http://dx.doi.org/10.1016/j.xocr.2017.11.001
,